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81st (Spring) Meeting of Ulster Society of Internal 
Medicine, Friday 15th May 2009
Medical Education Centre, Craigavon Hospital, Portadown
PROGRAMME:
2.00pm  Papers I
3.00pm  Invited  Abstract:  ‘Thrombolysis  for 
acute  ischaemic  stroke’  Dr  Ivan Wiggam, 
Consultant in Care of the Elderly Medicine, 
Belfast City Hospital. 
3.30pm  Afternoon Tea
3.50pm  Papers II
4.15pm      Presentation of prize for best abstract
4:50pm  Guest  lecture:  ‘Modern  Management  of 
Inflammatory  Bowel  Diseases’.  Dr  John 
Collins,  Consultant  Gastroenterologist, 
Royal Victoria Hospital, Belfast
PAPERS
S1. Trends in clinical outcome of patients admitted with 
ST  elevation  myocardial  infarction.  Insights  from The 
Heart Centre, Royal Victoria Hospital, Belfast.
NA McKeag, VN Kodoth, AJ Tomlin, SL Fairley, MJ Daly, 
AAJ Adgey.
The Heart Centre, Royal Victoria Hospital, Belfast Health and 
Social Care Trust, Belfast, UK.
Background: A decrease in incidence and major complication 
rate of ST elevation myocardial infarction (STEMI) has been 
observed across several population groups.
Methods  and  Results:  Information  on  patients  admitted 
to our centre with STEMI is entered into a computerised 
database. Data entered between January 2001 and December 
2007 were analysed; 945 patients were admitted over this 
time, 654 (69%) were male with an average age of 63, 291 
(31%) were female with an average age of 71. Admissions 
reduced  from  239  in  2001  to  76  in  2007. Thrombolysis 
was administered to 611 (65%) patients. Inpatient coronary 
angiography  was  performed  in  878  patients  (93%)  and 
817  patients  (86%)  underwent  percutaneous  coronary 
intervention (PCI). The proportion of patients undergoing 
coronary angiography and PCI increased from 79% and 61% 
respectively in 2001 to 99% and 95% in 2007. The overall 
in-patient mortality rate was 10%, decreasing from 11% in 
2001 to 3% in 2007. In total, 102 (11%) patients suffered 
cardiac arrest, decreasing from 9% in 2001 to 5% in 2007. 
Heart failure was noted in 284 (30%) patients, decreasing 
from 39% in 2001 to 11% in 2007. Major haemorrhage was 
noted in 41 (4%) patients, decreasing from 4% in 2001 to 
0% in 2007. In total, 7 (1%) patients suffered from a stroke. 
The average hospital stay decreased from 12.4 days in 2001 
to 8.8 days in 2007.
Conclusions:  This  study  demonstrates  decreasing  trends 
in  STEMI  admissions  and  major  complications  in  our 
centre. Recent in-patient mortality rates are low compared 
to those reported in major registries. This may reflect more 
aggressive primary and secondary prevention and increased 
implementation of invasive management strategies.
S2. ‘All in the eyes’: basilar tip occlusion, paroxysmal 
atrial fibrillation and mechanical clot retrieval. 
JJ  McKinley1,  E  Mawhinney2,  M  Watt2,  I  Rennie3,  MT 
McCormick1
Department  of  Medicine,  Daisy  Hill  Hospital,  Southern 
Trust,  Newry,  UK1.  Departments  of  Neurology2  and 
Neuroradiology3, Belfast HSC Trust, Belfast, UK.
A  73-year-old  lady  presented  with  unsteadiness  to  her 
local A&E department. She had been well the night before, 
gone to bed and awoke on two occasions with difficulty on 
mobilising to the bathroom. Medical attention was sought 
later that morning. Initial examination in A&E demonstrated 
a left sided internuclear opthalmoplegia and controlled atrial 
fibrillation (AF). She had a recent diagnosis of paroxysmal 
AF treated with aspirin and beta-blocker. Urgent CT Brain 
was  reported  as  normal.  Her  condition  fluctuated  within 
hours  of  admission.  She  developed  an  intermittent  dense 
right-sided hemiparesis, one and a half syndrome, dysarthria 
and  fluctuating  conscious  level.  Repeat  CT  Brain  with 
limited  CT  angiogram  suggested  a  patent  basilar  artery 
with  no  obvious  acute  ischaemic  changes.  The  clinical 
diagnosis was consistent with basilar artery occlusion.  In 
view of the fluctuating course and time to presentation she 
was  not  suitable  for  intravenous  thrombolysis.  Her  case 
was discussed with the regional neurosciences centre and 
she was transferred. Multi-slice CT angiography confirmed 
thrombus  in  the  upper  basilar  artery  and  she  underwent 
formal cerebral angiography, mechanical clot retrieval and 
resultant  recanalisation.  She  made  an  excellent  clinical 
recovery, remained in hospital for formal anticoagulation and 
discharged home later that week.        © The Ulster Medical Society, 2009.
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The prognosis of basilar artery occlusion is generally poor. 
This case demonstrates the potential devastating sequelae 
of atrial fibrillation, the need for prompt consideration of 
anticoagulation, limitations in single slice CT imaging, the 
importance of clinical acumen and the urgency in escalating 
therapy given the potential to restore circulation by means of 
novel therapies.   
S3.  Outcome  of  64-slice  multi-detector  coronary  CT 
angiogram when exercise stress test is equivocal or not 
possible.
JA Purvis, SM Hughes. 
Department  of  Cardiology, Altnagelvin  Hospital, Western 
HSC Trust, Londonderry, UK.
64-slice coronary CT angiography (64-CCTA) is currently 
being evaluated for patients at intermediate risk of coronary 
artery disease (CAD). We analysed data on patients referred 
to us because of equivocal EST result or technical problem.
Pre-treatment with oral beta-blockade was used to achieve 
HR<64bpm. Intravenous beta-blocker was given pre-test if 
required. Sublingual GTN was given to all. A calcium scan 
was performed then contrast study.
89 patients were referred over 15 months. 53(60%) had an 
equivocal EST result, 6(7%) had inadequate exercise duration, 
15(17%) had mobility problems, 8(9%) had LBBB, 3(3%) 
had COPD, 2(2%) had hypertension or LVF, 2(2%) didn’t 
want to EST.
All calcium scans were evaluable. 65(74%) patients had mild 
calcification (Agatston score = 0 – 100), [41(46%) had a score 
of 0]. 12 had moderate (13%) calcification (Agatston score = 
101 – 300) and 12(13%) had severe calcification (Agatston 
score >300).
In 5 cases, calcium score was too high for contrast study. 
84  contrast  studies  were  performed,  all  were  evaluable, 
47(56%) patients had normal studies. 23(27%) patients had 
mild coronary plaque not requiring catheter study. 13(15%) 
patients had severe coronary plaque and underwent catheter 
study. Cath agreed with 64-CCTA in 10(77%), 64-CCTA 
over-called 2(15%) cases and under-called 1(8%). 
In conclusion, 64-CCTA can exclude CAD in 56% of this 
category of patients. In a further 27% non-obstructive plaque 
is seen. 64-CCTA shows a high correlation with cath findings 
for severe plaque. 
S4. The outcome of fixed dose radioiodine (550MBq) in the 
treatment of relapsed hyperthyroidism
AS Lewis, T Rea, AB Atkinson, PM Bell, CH Courtney, DR 
McCance, K Mullan, SJ Hunter.
The Regional Centre for Endocrinology and Diabetes, Royal 
Victoria Hospital, Belfast, UK. 
Radioiodine  is  the  treatment  of  choice  for  relapsed 
hyperthyroidism although the optimum protocol is uncertain. 
We  assessed  the  outcome  of  therapy  with  radioiodine  in 
relapsed hyperthyroidism using a fixed dose regimen. 
We  retrospectively  studied  449  patients  (M:  F  82:367; 
age range 13-89y, median 42y) treated between 2003 and 
2007 with a fixed dose of 550MBq radioiodine for relapsed 
hyperthyroidism. Patients were classified as Graves’ disease, 
toxic multinodular goitre or indeterminate aetiology. Where 
patients were on antithyroid drugs these were stopped at least 
1 week prior to radioiodine.  
One  year  following  radioiodine  334  patients  (74%)  were 
hypothyroid,  85  (19%)  were  euthyroid  and  30  (7%)  had 
required a further dose of radioiodine. Patients with Graves’ 
disease were more likely to become hypothyroid than those 
with toxic multinodular goitre (78% v 37%, p<0.001) whereas 
the latter were more likely to become euthyroid (55% v 11%, 
p<0.001).  Free  thyroxine  >80pmol/L  at  presentation  was 
associated with an increased failure rate (17% compared with 
5% and 3% for 40-79pmol/L and <40pmol/L respectively; p 
= 0.01).   Patients with a small / no goitre were more likely 
to be successfully treated by a single dose of radioiodine 
(96%) than those with a medium/large goitre (85%, p<0.001). 
Anti-thyroid medication was taken by 345 patients (77%) 
(carbimazole n = 319) and was associated with an increased 
failure rate (8% v 2%, p = 0.027).
In conclusion, a single fixed dose of 550MBq radioiodine 
is highly effective in treating relapsed hyperthyroidism. The 
aetiology, severity of hyperthyroidism, goitre size and prior 
anti-thyroid medication have a significant effect on outcome.   
S5. PSD502, a novel metered-dose, aerosol formulation of 
lidocaine and prilocaine, is a safe and effective treatment 
for premature ejaculation (PE); results of a phase III, 
randomized, double blind, placebo-controlled study.
Wallace Dinsmore, Michael G Wyllie, Patricia Heath
Royal Victoria Hospital, Belfast, UK. 
Introduction  and  Objective:  Reducing  the  sensitivity 
of  the  glans  penis  with  topical  desensitizing  agents  in 
men  with  premature  ejaculation  may  represent  a  way  of 
improving  intravaginal  ejaculatory  latency  time  (IELT) 
without  adversely  affecting  the  sensation  of  ejaculation. 
PSD502  is  a  novel  aerosol  formulation  of  lidocaine  and 
prilocaine,  which  selectively  desensitizes  non-keratinized 
skin. The objectives of this study were to assess the clinical 
benefit and safety of PSD502 or placebo in men with PE 
when applied to the glans penis on an ‘as needed’ basis. 
Methods: A total of 300 men with primary PE diagnosed 
according to the recently published ISSM definition (including 
an IELT of £ 1 minute), were randomized from 32 centres in 
UK, Czech Republic, Hungary and Poland to apply 3 sprays 
of PSD502 or placebo (double-blind) to the glans penis 5 min 
before intercourse. Efficacy was assessed by changes in IELT, 
Index of Premature Ejaculation (IPE; a patient-rated scale of 
improvement in ejaculatory control, sexual satisfaction, and 
distress), and Premature Ejaculation Profile (PEP; patient 
and partner-rated scales of improvement in PE symptoms). 
Subjects were followed up at intervals for 3 months and offered 
open label treatment with PSD502 for a further 9 months.   
Results: Preliminary analyses show that PSD502 produced 
a highly clinically and statistically significant increase from 
baseline  in  all  three  co-primary  endpoints.  Both  groups 
had  a  geometric  mean  baseline  IELT  of  0.6  min,  which 
increased  to  4  min  in  the  PSD502  group  compared  to  1 © The Ulster Medical Society, 2009.
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min in the placebo group (p<0.0001). There was a 7-point 
difference between PSD502 and placebo in the IPE domain 
for ejaculatory control (p<0.0001) and a 6-point difference 
in the IPE domain for sexual satisfaction (p<0.0001). These 
positive results were supported by similar improvements in 
secondary endpoints. There were no serious adverse events 
and only 2.6% of patients reported treatment-related adverse 
events  in  the  PSD502  group  compared  with  1%  in  the 
placebo group. PSD502 was well tolerated by both patients 
and partners, and with no systemic adverse events reported. 
Conclusions: This large placebo-controlled study indicates 
that PSD502 is a safe and effective treatment for primary 
PE, when applied 5 min before intercourse, demonstrating 
highly significant improvements in IELT and patient-rated 
improvement scales and a good safety profile in both patients 
and their partners.
S6. Takotsubo cardiomyopathy in preoperative patients 
with pain: a report of two cases
MJ Daly, LJ Dixon 
Regional Medical Cardiology Centre, Royal Victoria Hospital, 
Belfast, UK
Reversible  stress-induced  cardiomyopathy,  i.e.  Takotsubo 
cardiomyopathy, rarely presents in preoperative patients. We 
provide the case reports of two patients who presented to 
hospital with uncontrolled pain from an acutely ischaemic 
limb and femoral neck fracture, with an absence of chest 
pain. Electrocardiogram revealed dynamic T-wave inversion, 
with peak Troponin-T elevation in each case, i.e. 0.66ug/L 
and  0.14ug/L  (NR  <0.03ug/L).  Despite  these  findings 
consistent with acute myocardial infarction, neither patient 
had  obstructive  coronary  disease  at  angiography.  Left 
ventriculography  at  this  time  showed  moderate  systolic 
functional impairment with apical ballooning. This feature is 
pathognomonic of the Takotsubo syndrome, which we surmise 
was  due  to  excess  endogenous  catecholamine  production 
in response to acute pain in these patients. All features of 
ventricular dysfunction had resolved completely at repeat 
echocardiography  two-weeks  later,  following  definitive 
vascular/orthopaedic surgery to their lower limbs. 
Patients with Takotsubo cardiomyopathy have been shown 
to possess higher catecholamine levels than patients with 
myocardial  infarction  in  the  same  Killip  class1.  Apical 
myocardium  is  particularly  receptive  to  sympathetic 
stimulation,  resulting  in  characteristic  ballooning  as  seen 
in  our  patients.  Furthermore,  catecholamine  stress-injury 
is  likely  to  be  present  in  a  number  of  disorders  whose 
common  phenotypic  expression  is  that  of  regional  wall 
motion  abnormality,  e.g.  subarachnoid  haemorrhage, 
phaeochromocytoma,  acute  asthma  and  Guillain-Barré 
syndrome.
Treatment  of  Takotsubo  cardiomyopathy  remains  largely 
pragmatic,  with  standard  supportive  care  and  treatment 
of complications, e.g. pulmonary oedema. Recent reports 
attribute 12% of all cases to non-cardiac surgery/procedures 
and 4% to skeletal fractures2. Although this syndrome remains 
uncommon,  it  should  be  considered  in  any  patient  with 
symptoms suggestive of an acute coronary syndrome, when 
the electrocardiographic changes are disproportionate to the 
cardiac enzyme rise, and particularly those in acute pain. 
1. Wittstein IS, Theimann DR, Lima JA, et al. Neurohumoral features of myocardial 
stunning due to sudden emotional stress.  New Eng J Med 2005;352:539-48. 2. Elesber 
AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year Recurrence Rate 
and Prognosis of the Apical Ballooning Syndrome. J Am Coll Cardiol 2007;50:448-52
S7.  Day  Case  Percutaneous  Coronary  Intervention  in 
Selected Patients – A Pilot Study in Northern Ireland
EC Hodkinson, J Shand, DJ Flannery, DJ McEneaney, IBA 
Menown, AJ McClelland, SJ Walsh. 
Cardiology Department, Craigavon Area Hospital, Craigavon, 
UK. 
Further  to  the  development  of  intracoronary  stents  post-
procedural complications rates after percutaneous coronary 
intervention (PCI) are low. Acute complications post-PCI 
occur almost exclusively within six hours1,2, therefore day 
case PCI is both feasible and safe. 
Day  case  PCI  has  been  performed  in  Craigavon  since 
November 2008. Patients are discharged after 6 hours if there 
has been a successful PCI (TIMI 3 flow and <20% residual 
stenosis of the target lesion) and they meet criteria for same 
day discharge. Exclusion criteria include: unstable patients 
(ischaemia or loss of a side branch >1mm, instability during 
the PCI or LVF), any vascular complication or a sub-optimal 
technical result.
The first 100 cases are presented: 71% were male; mean 
age  was  64  (range  42-84  yrs).  LV  function  was  severely 
impaired in 2% and moderately impaired in 16%. A total of 
105 lesions were treated, 46% of which were high risk (AHA/
ACC classification) and 36% moderate risk. A total of 129 
stents were deployed, 78 (60%) of these were drug eluting. 
To date, 30-day follow-up is available for 70 patients. There 
have been no major adverse cardiac events (death, MI, CVA) 
or other adverse events (repeat angiography/PCI, contrast 
induced nephropathy, CK rise > 2x the upper limit of normal). 
Follow-up for all 100 cases will be presented at the meeting. 
The total cost saving from preventing a single overnight stay 
for each patient is £47,100.
Day Case PCI in selected cases is safe, feasible and offers 
substantial cost savings to the local health service.
1Small A, Klinke P, Della Siega A et al. Day Procedure intervention is safe and 
complication free in higher risk patients undergoing transradial angioplasty and 
stenting. The Discharge Study. Catheter Cardiovasc Inter 2007;70:907-12. 2Koch KT, 
Piek JJ, Prins MH et al. Triage of Patients for short term observation after elective 
angioplasty. Heart 2000;83:556-563.